are glp 1's safe GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Compounded GLP-1s: A Safe &

Key Insights: Improved Asthma Control: Patients on GLP1 showed significantly better asthma control based on Risk Domain Asthma Control (RDAC) and Overall Asthma Control (OAC) measures

The MotherToBaby position MotherToBaby, a service of the Organization of Teratology Information Specialists, notes that while studies are limited, the available data on injectable semaglutide and tirzepatide suggest low risk during breastfeeding

A patient with commercial UnitedHealthcare coverage for Wegovy loses coverage when transitioning to UnitedHealthcare Medicare Advantage, even if staying with the same insurer

Best results are achieved when combined with a full weight-loss program

2-3 times per week is a typical dosage, depending on your goals and bodys response

REDEFINE 1 and REDEFINE 2 are completed phase 3 trials published in NEJM with over 4,600 participants